胺碘酮在急诊治疗快速型心律失常复律中的效果

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (450 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Amiodarone on the emergency treatment of tachyarrhythmia cardioversion.Methods From January 2018 to January 2020,72 patients with tachyarrhythmia admitted to the Department of Emergency Medicine of Zhongguancun Hospital in Beijing were selected as the research objects,and they were divided into control group(n=36)and observation group(n=36)using random number table method.The control group was treated with Propafenone,and the observation group was treated with Amiodarone.The total effective rate,heart rate(HR),diastolic blood pressure(DBP),systolic blood pressure(SBP),PR interval,QT interval and incidence of adverse reactions of the two groups were compared before and after treatment.Results The total effective rate of treatment in the observation group was higher than that in the control group,and the difference was statistically significant(P＜0.05).HR,DBP and SBP of the two groups after treatment were lower than those before treatment and the indexes of the observation group were lower than those of the control group,the differences were statistically significant(P＜0.05);after treatment in the two groups were longer than before treatment,and the PR interval and QT interval in the observation group after treatment were longer than those in the control group,the differences were statistically significant(P＜0.05).The total incidence of adverse reactions in the observation group was lower than that in the control group,and the difference was statistically significant(P＜0.05).Conclusion Amiodarone has a definite effect on the emergency treatment of tachyarrhythmia cardioversion,which can keep the patient's heart rate stable,with few adverse reactions and high safety.

Key words： Emergency department Tachyarrhythmia Amiodarone Propafenone Cardioversion Adverse reactions

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Miaomiao
	ZHANG Jiangyi
	TIAN Lihong

Cite this article:

CHEN Miaomiao,ZHANG Jiangyi,TIAN Lihong. Effect of Amiodarone in emergency treatment of tachyarrhythmia cardioversion[J]. 中国当代医药, 2022, 29(10): 67-70.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I10/67

[1]	Yazaki K，Ejima K，Kataoka S，et al.Prognostic Significance ofPost-ProceduralLeftVentricularEjectionFractionFollowing Atrial Fibrillation Ablation in Patients With Systolic Dysfunction：Arrhythmia/Electrophysiology[J].Circ Rep，2020，2（12）：707-714.
[2]	王冠男，李勇，张健，等.美托洛尔联合胺碘酮治疗冠心病合并心律失常的临床疗效观察[J].中华老年心脑血管病杂志，2018，20（9）：932-935.
[3]	吕萍，金光临，曾丽萍，等.胺碘酮联合β 受体阻滞剂对急性心肌梗死并心律失常患者心功能的影响[J].西北药学杂志，2018，33（2）：250-252.
[4]	夏雷风，谢宗贤，裴杰，等.胺碘酮联合美托洛尔对心律失常病人心功能和心肌标志物的影响[J].中西医结合心脑血管病杂志，2018，16（18）：2673-2677.
[5]	周晓丹，潘磊，王磊，等.门冬氨酸钾镁联合胺碘酮对慢性心力衰竭合并心律失常患者心功能、血液流变学和炎性因子的影响[J].疑难病杂志，2018，17（10）：1089-1093.
[6]	郝春颖，黄园园.胺碘酮、普罗帕酮对老年心律失常患者心率变异及高敏C 反应蛋白的影响[J].中国老年学杂志，2018，38（6）：1328-1330.
[7]	李西红，孙黎博.胺碘酮联合美托洛尔治疗急性心肌梗死合并心律失常患者的效果及对患者心脏功能的影响分析[J].山西医药杂志，2019，48（22）：2734-2737.
[8]	杜春蕾，郭牧，张云强，等.尼非卡兰与胺碘酮治疗严重室性心律失常近期疗效及安全性的对比研究[J].临床心血管病杂志，2019，35（2）：149-153.
[9]	张志敏，高淑梅，侯瑞田，等.美托洛尔联合胺碘酮治疗慢性心力衰竭合并室性心律失常患者的临床研究[J].中国临床药理学杂志，2020，36（10）：1180-1182，1190.
[10]	李延辉，陈瑶，黄莺，等.胺碘酮联合磷酸肌酸钠治疗室性心律失常疗效及对血清NF-κB、CD40L 水平的影响[J].疑难病杂志，2019，18（4）：334-338.
[11]	曹钰，李东泽，余海放，等.2018年美国心脏协会心肺复苏与心血管急救指南更新解读——抗心律失常药物在成人心脏骤停高级生命支持及自主循环恢复后的应用[J].华西医学，2018，33（11）：1352-1355.
[12]	张伟民，陈谨献，陈豪，等.琥珀酸美托洛尔联合胺碘酮对心律失常患者心功能及生活质量评分的影响[J].中国临床保健杂志，2020，23（2）：233-236.
[13]	王元明，郭任维，郭润民.胺碘酮对心律失常患者心功能、心率变异性及血清炎性因子水平的影响[J].中国临床药理学杂志，2020，36（7）：737-740.
[14]	陈志亮，曹文伟.快速型心律失常的急诊临床治疗方法分析[J].岭南急诊医学杂志，2018，23（01）：34-36.
[15]	田瑜，崔苗，宋庆桥，等.胺碘酮联合参松养心胶囊治疗心力衰竭合并心律失常有效性及安全性的Meta 分析[J].中西医结合心脑血管病杂志，2020，18（12）：1852-1857.
[16]	纪淑娟，刘建邦.心可舒片治疗冠心病快速型心律失常的临床疗效评价[J].临床医药文献电子杂志，2020，7（30）：5.
[17]	王景晶.胺碘酮抗心律失常机制及急诊急救应用价值——评《抗心律失常药物临床指南》[J].中国医学装备，2020，17（8）：220-221.
[18]	王胜利.院前急救治疗快速型心律失常中应用胺碘酮的效果及安全[J].中国药物与临床，2020，20（24）：4126-4128.